A Study to Determine Human Papillomavirus Vaccine Hesitancy in the Mayo Clinic Cancer Center Serving Area
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 20-006625
Sponsor Protocol Number: 20-006625
About this study
Reducing the HPV-associated cancer burden in rural populations will require research to better understand vaccine hesitancy to guide development of novel interventions. We propose to identify HPV vaccine-hesitant populations in our catchment area and characterize key factors that influence hesitancy in our substantially rural population where HPV vaccine uptake is unacceptably low. To this end, we will pursue the following specific aims:
Aim 1. Conduct a population-based survey of parents of HPV vaccine eligible age children in the Mayo Clinic Cancer Center Midwest catchment area population to identify those with high vaccine hesitancy and assess the association of hesitancy with on-time HPV vaccine uptake (by age 13) overall and by urban/rural status, area-level socioeconomic indicators, and clinical practice site.
Aim 2. Conduct theoretically-grounded focus groups with parents of HPV-vaccine-eligible-aged children to evaluate psychosocial and communication factors that influence parental attitudes toward HPV vaccination in populations with low rates of uptake and expected high HPV vaccine hesitancy (per Aim 1).
Aim 3. Conduct interviews with clinicians, nurses, and administrators at clinical practices with low HPV vaccination initiation rates serving patients with vaccine hesitancy to assess clinician knowledge, attitudes, and behavior relevant to HPV vaccine hesitancy (per Aims 1 and 2).
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria - Aim 1
- Parents that are 18 years or older with children aged between 13-18.
- Parents who have the decision making authority for their child.
- Reside in the Midwest Mayo Clinic Cancer Center catchment area (either of the 12 sites listed).
- Able to speak and understand English.
Exclusion Criteria - Aim 1
- Parents who do not have decision-making authority for their child.
- Not able to speak and understand English.
- Not residing in the Midwest Mayo Clinic Center catchment area.
Inclusion Criteria- Aim 2
- Parents must be 18 years old
- Able to speak and understand English
- Have decision-making authority over there child
- Have access to an internet-enabled electronic device
- Have an e-mail address
Exclusion Criteria- Aim 2
- Parents not under the age of 18
- Not able to speak and understand English
- Do not have decision-making authority over there child
- Do not have access to an internet-enabled electronic device
Inclusion Criteria - Aim 3:
- Must be clinical staff (physicians, nurse-practitioners, physician assistants, nurses, reception staff, and administrators).
- Must work in the Midwest Mayo Clinic Center catchment area.
Exclusion Criteria - Aim 3:
- Not clinical staff.
- Does not work in Midwest Mayo Clinic Center catchment sites.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Lila Rutten, Ph.D.
Closed-enrolling by invitation
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available